Target intelligence / Profile preview

Lysosome-Autophagosome Fusion via MTORC1 Pathway (N/A)

Target
N/A
Molecular classification
Pathway, Cellular Process
01

Overview

Lysosome-autophagosome fusion, regulated by the MTORC1 pathway, is a critical step in autophagy, enabling the degradation and recycling of cellular components. Active MTORC1, stimulated by nutrient availability, inhibits autophagy initiation and lysosomal function. Conversely, MTORC1 inactivation promotes autophagy. The fusion process involves Rab GTPases, SNARE proteins, tethering factors, and phosphoinositides. Dysregulation is implicated in various diseases, highlighting the importance of controlled autophagy.

Other names
Autophagy FluxAutolysosome FormationMTORC1-regulated AutophagyLysosomal Degradation Pathway
02

Mechanism of action

Varies depending on the specific intervention; MTOR inhibitors promote autophagy by de-repressing ULK1/2 and TFEB. Lysosomotropic agents disrupt lysosomal pH and function, impairing autophagic degradation.

03

Biological functions

AutophagyLysosomal DegradationCellular HomeostasisNutrient SensingProtein TurnoverOrganelle Turnover
04

Disease associations

Neurodegenerative DiseaseCancerAgingMetabolic DisordersInfection
05

Safety considerations

Off-target effects of autophagy modulatorsPotential for promoting or inhibiting autophagy inappropriatelyDrug resistance development
06

Interacting drugs

Rapamycin

3 more in the full profile.

07

Biomarkers

LC3-II levelsp62/SQSTM1 levelsAutophagy flux assays (e.g., using Bafilomycin A1)TFEB activity/localizationMTORC1 activity (e.g., p-S6K, p-4E-BP1)

Beyond the preview

Go deeper on Lysosome-Autophagosome Fusion via MTORC1 Pathway (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosome-Autophagosome Fusion via MTORC1 Pathway (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call